ATE419842T1 - Abgabevehikel mit nanoteilchen - Google Patents

Abgabevehikel mit nanoteilchen

Info

Publication number
ATE419842T1
ATE419842T1 AT05784613T AT05784613T ATE419842T1 AT E419842 T1 ATE419842 T1 AT E419842T1 AT 05784613 T AT05784613 T AT 05784613T AT 05784613 T AT05784613 T AT 05784613T AT E419842 T1 ATE419842 T1 AT E419842T1
Authority
AT
Austria
Prior art keywords
nanoparticles
delivery vehicles
vehicles
present
directed
Prior art date
Application number
AT05784613T
Other languages
English (en)
Inventor
Kerstin Ringe
Hans-Eckart Radunz
Katharina Landfester
Clemens Weiss
Original Assignee
Nanodel Technologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04027997A external-priority patent/EP1661559A1/de
Application filed by Nanodel Technologies Gmbh filed Critical Nanodel Technologies Gmbh
Application granted granted Critical
Publication of ATE419842T1 publication Critical patent/ATE419842T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
AT05784613T 2004-09-14 2005-09-14 Abgabevehikel mit nanoteilchen ATE419842T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04021855 2004-09-14
EP04027997A EP1661559A1 (de) 2004-11-25 2004-11-25 Verabreichungssystem hergestellt durch ein Miniemulsionsverfahren

Publications (1)

Publication Number Publication Date
ATE419842T1 true ATE419842T1 (de) 2009-01-15

Family

ID=35788673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05784613T ATE419842T1 (de) 2004-09-14 2005-09-14 Abgabevehikel mit nanoteilchen

Country Status (11)

Country Link
US (1) US20070292524A1 (de)
EP (1) EP1796650B1 (de)
JP (1) JP2008513363A (de)
CN (1) CN101072553A (de)
AT (1) ATE419842T1 (de)
CA (1) CA2579957A1 (de)
DE (1) DE602005012289D1 (de)
DK (1) DK1796650T3 (de)
ES (1) ES2318531T3 (de)
PL (1) PL1796650T3 (de)
WO (1) WO2006029845A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1713514B1 (de) * 2004-01-28 2021-11-24 Johns Hopkins University Arzneimittel und genträgerteilchen, die sich schnell durch schleimhautbarrieren bewegen
EP1815851A1 (de) * 2006-02-03 2007-08-08 NanoDel Technologies GmbH Nanopartikel zur Arzneistoffverabreichung
EP1876188A1 (de) * 2006-07-04 2008-01-09 NanoDel Technologies GmbH Zweistufiges Polymerisationsverfahren in Miniemulsion
EP2061433B1 (de) * 2006-09-08 2011-02-16 Johns Hopkins University Zusammensetzungen zur transportintensivierung durch die schleimhaut
US7984714B2 (en) * 2006-09-29 2011-07-26 Nellcor Puritan Bennett Llc Managing obstructive sleep apnea and/or snoring using local time released agents
US8512697B2 (en) * 2007-05-16 2013-08-20 The University Of North Carolina At Chapel Hill Delivery of micro- and nanoparticles with blood platelets
EP2271323A2 (de) 2008-05-06 2011-01-12 Glaxo Group Limited Einkapselung biologischer wirkstoffe
US8888736B2 (en) 2010-04-30 2014-11-18 H R D Corporation High shear application in medical therapy
BR112012027651A2 (pt) 2010-04-30 2016-08-16 H R D Corp método, e, sistema
WO2012074588A2 (en) 2010-08-30 2012-06-07 President And Fellows Of Harvard College Shear controlled release for stenotic lesions and thrombolytic therapies
EP2640426B1 (de) * 2010-11-16 2016-02-03 Selecta Biosciences, Inc. Immunstimulierende oligonukleotide
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
ES3055223T3 (en) 2012-05-03 2026-02-10 Alcon Inc Pharmaceutical nanoparticles showing improved mucosal transport
WO2013166487A1 (en) 2012-05-04 2013-11-07 Yale University Highly penetrative nanocarriers for treatment of cns disease
GB201304245D0 (en) * 2013-03-08 2013-04-24 Inst Quimic De Sarria Chemical compounds
CN104231137A (zh) * 2014-10-10 2014-12-24 河北科技大学 一种聚合物包埋疏水性抗肿瘤药物纳米复合微球的制备方法
KR101903536B1 (ko) * 2015-12-31 2018-10-02 후아웨이 테크놀러지 컴퍼니 리미티드 데이터 기입 방법, 장치, 및 시스템
KR20230088732A (ko) 2020-09-29 2023-06-20 옥스포드 유니버시티 이노베이션 리미티드 뇌졸중 치료
JP2022080126A (ja) * 2020-11-17 2022-05-27 三菱鉛筆株式会社 肥料粒子
PL247686B1 (pl) * 2023-02-21 2025-08-18 Inst Katalizy I Fizykochemii Powierzchni Im Jerzego Habera Polskiej Akademii Nauk Sposób wytwarzania wielordzeniowego nanonośnika polielektrolitowego syntetyzowanego na bazie siarczanu dodecylu sodu i wielordzeniowy nanonośnik polielektrolitowy do zastosowania do leczenia w terapii przeciwnowotworowej
CN116925337B (zh) * 2023-09-19 2023-12-01 广东药科大学 一种多巴胺衍生物的靶向型纳米载体构建的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5569509A (en) * 1979-11-30 1980-05-26 Mcleod Patrick Biologically decomposable particle
FR2504408B1 (fr) * 1981-04-24 1986-02-14 Couvreur Patrick Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
JPS6061521A (ja) * 1983-09-16 1985-04-09 Kyowa Hakko Kogyo Co Ltd マイクロカプセル化製剤
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
WO1995022963A1 (en) * 1994-02-28 1995-08-31 Medinova Medical Consulting Gmbh Drug targeting system, method for preparing same and its use
CA2295177C (en) * 1997-06-13 2007-01-09 Medinova Medical Consulting Gmbh Drug targeting system, method of its preparation and its use
AUPO888097A0 (en) * 1997-08-29 1997-09-25 Biotech Australia Pty Limited Cross-linked particles
JP4272811B2 (ja) * 1997-09-05 2009-06-03 マルホ株式会社 関節内疾患治療用のナノカプセル製剤
FR2775435B1 (fr) * 1998-02-27 2000-05-26 Bioalliance Pharma Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
CA2445125A1 (en) * 2001-03-21 2002-10-03 University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
FR2841137B1 (fr) * 2002-06-20 2004-08-13 Bioalliance Pharma Systeme de vectorisation comprenant des nanoparticules de taille homogene d'au moins un polymere et d'au moins un polysaccharide charge positivement
ATE408398T1 (de) * 2002-07-29 2008-10-15 Nanodel Technologies Gmbh Nanopartikele für dna verabreichung zu einem zielorgan

Also Published As

Publication number Publication date
WO2006029845A3 (en) 2006-07-20
EP1796650A2 (de) 2007-06-20
PL1796650T3 (pl) 2009-06-30
EP1796650B1 (de) 2009-01-07
ES2318531T3 (es) 2009-05-01
DE602005012289D1 (de) 2009-02-26
DK1796650T3 (da) 2009-03-09
CN101072553A (zh) 2007-11-14
CA2579957A1 (en) 2006-03-23
US20070292524A1 (en) 2007-12-20
JP2008513363A (ja) 2008-05-01
WO2006029845A2 (en) 2006-03-23

Similar Documents

Publication Publication Date Title
ATE419842T1 (de) Abgabevehikel mit nanoteilchen
DE502007006208D1 (de) Neue 1,4-benzothiepin-1,1-dioxidderivate mit verbesserten eigenschaften, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EA200801460A1 (ru) Рекомбинантные моновалентные антитела и способы их получения
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
WO2006039704A3 (en) Pharmaceutical composition and method for treating a joint capsule arthropathy
NZ595313A (en) The Use Of Nanoparticles Comprising Rapamycin Or Taxane In The Treatment Of Proliferative Diseases
WO2005089106A3 (en) Degradable nanoparticles
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
NI201200013A (es) Composición de insulina de acción prolongada
CR11472A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
DE502007002772D1 (de) Neue mit cyclohexylresten substituierte1,4-benzothiepin-1,1 -dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2007085629A3 (en) Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
CR10270A (es) Medicamentos que contienen fluoroquinolonas
WO2006018184A3 (de) Spirocyclische cyclohexan-derivate
WO2007093975A3 (es) Uso del factor pedf para inducir la renovación de células
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
MX337358B (es) Conjugados de disorazoles y sus derivados con moleculas de union con celulas, nuevos derivados de disorazol, procesos de fabricacion y usos de los mismos.
WO2008051527A3 (en) Sustained release of agents for localized pain management
DE502007002949D1 (de) Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel
ATE425961T1 (de) Salze substituierter allophansaureester und deren verwendung in arzneimitteln
WO2007114946A3 (en) Acid-sensitive linkers for drug delivery
PH12013502048B1 (en) Therapeutic treatment

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties